FDA Inspection
Omega Biological Laboratories Inc.Omega Biological Laboratories Inc. – FDA Inspection, Nov 7, 2018
Record Details
This FDA Inspection record concerns Omega Biological Laboratories Inc., with an inspection on November 7, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · e192b84a-887c-4743-a550-64a0dbef9b73
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1071303
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 211.165(b)Microbiological testing
- 21 CFR 211.194(a)(4)Complete Test Data
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Omega Biological Laboratories Inc.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| July 31, 2025 | VAI | New Jersey District Office | Drug Quality Assurance |
| June 25, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 14, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 15, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 9, 2010 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Omega Biological Laboratories Inc.
- FDA Inspection 1277045 - 2025-07-31
- FDA Inspection 884889 - 2014-06-25
- FDA Inspection 779782 - 2012-05-14
- FDA Inspection 730031 - 2011-06-15
- FDA Inspection 672552 - 2010-07-09
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.